BIOREGENX, INC. (BRGX) — Annual Report

Key Insights

• BioRegenX reported a significant year-over-year increase in sales revenue, driven primarily by growth in its medical testing and wellness devices segments.
• The company acquired DocSun Biomedical Holdings, which expanded its product portfolio and distribution capabilities, potentially enhancing future growth opportunities.
• BioRegenX secured several new customer contracts and partnerships, including a royalty-bearing license agreement for its GlycoCheck technology, diversifying its revenue streams.